Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy
ICD-10 E10.33 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy.
E10.33 refers to Type 1 diabetes mellitus, a chronic condition characterized by the body's inability to produce insulin due to autoimmune destruction of pancreatic beta cells. This specific code indicates the presence of moderate nonproliferative diabetic retinopathy (NPDR), a common complication of diabetes that affects the retina. NPDR is characterized by the presence of microaneurysms, retinal hemorrhages, and exudates, which can lead to vision impairment if left untreated. The classification of diabetic retinopathy into mild, moderate, and severe NPDR is based on the extent of retinal damage and the presence of specific retinal findings. Patients with E10.33 often require regular eye examinations and may need interventions such as laser therapy or intravitreal injections to manage their condition. Effective management of Type 1 diabetes, including maintaining optimal HbA1c levels (generally below 7% for most adults), is crucial in preventing or delaying the onset of diabetic retinopathy and other complications. Insulin therapy is the cornerstone of treatment for Type 1 diabetes, and patients may use multiple daily injections or insulin pumps to achieve glycemic control.
Detailed records of insulin therapy, HbA1c levels, and diabetes management plans.
Patients presenting with uncontrolled diabetes, requiring insulin adjustments.
Ensure documentation reflects the patient's diabetes management and any complications.
Comprehensive eye examination reports, including findings related to diabetic retinopathy.
Patients undergoing routine eye exams for diabetic retinopathy screening.
Document the severity of retinopathy and any treatments provided.
Used during routine eye exams for diabetic retinopathy screening.
Document findings of the eye exam and any treatments provided.
Ophthalmologists should ensure that the severity of retinopathy is documented.
Coding E10.33 is significant as it indicates the presence of moderate nonproliferative diabetic retinopathy in a patient with Type 1 diabetes, which is crucial for treatment planning and monitoring of potential vision loss.
Patients with E10.33 should have comprehensive eye exams at least annually, or more frequently if recommended by their ophthalmologist, to monitor the progression of diabetic retinopathy.
